66 - Lipid-lowering therapy| Volume 235, ISSUE 2, e252, August 2014

The hypolipidemic and hepatoprotective efficacies of a essential phospholipids with methionine and atorvastatin in patients with cardiovascular diseases and diabetes mellitus

      Objectives: to study the hypolipidemic and hepatoprotective activity of the fixed-dose essential phospholipids with methionine (EPL+M) - Eslidine in the combination with Atorvastatin (A) in patients (pts) with cardiovascular diseases (CVD), type 2 diabetes mellitus (DM) and hyperlipidemia (HL).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect